skip to primary navigationskip to content
 

Drug Discovery Seminar

From Target to Preclinical Candidate Nomination: WHICH data is required WHEN and WHY? A training seminar for Cambridge academics, clinicians, early-career researchers and biotech-based industry professionals
When May 10, 2017
from 01:30 PM to 04:30 PM
Where Pavilion Room, Hughes Hall, Cambridge, CB1 2EW
Add event to calendar vCal
iCal

 

 Professional drug hunter Dr Olaf Ritzeler from Sanofi will talk through the drug discovery pathway from target selection to preclinical candidate nomination and focus in on data requirements – covering computational modelling & ‘omics’, through pharmacokinetics & pharmacodynamics to drug safety, regulatory and commercial data needs. 

Join us to discover how the right datasets are crucial for the creation of new medicines. 

Book online at https://drug-discovery-data-requirements-cambridge.eventbrite.com 

Follow us on Twitter: @CambridgeATS @TheMilnerInst

Upcoming events

Immunogenomics of Disease: Accelerating to Patient Benefit

Feb 05, 2019

Wellcome Genome Campus, UK

Upcoming events

The new Capella building- CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Capella building will be finished in 2018.

Fibroblast

‘Fibroblast’ has been developed from a conversation between Harold Offeh and Dr Alice Denton, a scientist based at the Babraham Institute and a member of the Cambridge Immunology Network. Offeh was particularly interested in the character and roles played by particular cells in the immune system, as well as the immune system’s role as a primary source of protection and care. The film takes as a starting point microscopic images of broblast cells, an area of research for Dr Denton.

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more